Smoking as a major risk factor for cervical cancer and pre-cancer: Results from the EPIC cohort

International Journal of Cancer

Volumn 135, Issue 2, 2014, Pages 453-466

  Roura, Esther ^a,b   Castellsagué, Xavier ^a,b   Pawlita, Michael ^c   Travier, Noémie ^a   Waterboer, Tim ^c   Margall, Núria ^d   Bosch, F Xavier ^a   De Sanjosé, Silvia ^a,b   Dillner, Joakim ^e   Gram, Inger T ^f   Tjønneland, Anne ^g   Munk, Christian ^g   Pala, Valeria ^h   Palli, Domenico ⁱ   Khaw, Kay Tee ^j   Barnabas, Ruanne V ^k,l   Overvad, Kim ^m   Clavel Chapelon, Françoise ^n,o,p   Boutron Ruault, Marie Christine ^n,o,p   Fagherazzi, Guy ^n,o,p   Kaaks, Rudolf ^c   Lukanova, Annekatrin ^c,q   Steffen, Annika ^r   Trichopoulou, Antonia ^s,t   Trichopoulos, Dimitrios ^s,u,v   Klinaki, Eleni ^s   Tumino, Rosario ^w   Sacerdote, Carlotta ^x   Panico, Salvatore ^y   Bueno De Mesquita, H B ^z,aa,ab   Peeters, Petra H ^z,ab   Lund, Eiliv ^f   Weiderpass, Elisabete ^e,f,ac,ad   Redondo, M Luisa ^ae   Sánchez, María José ^b,af,ag   Tormo, Maria José ^b,ah,ai   Barricarte, Aurelio ^b,aj   Larrañaga, Nerea ^b,ak   Ekström, Johanna ^al   Hortlund, Maria ^al   Lindquist, David ^q   Wareham, Nick ^j   Travis, Ruth C ^am   Rinaldi, Sabina ^an   Tommasino, Massimo ^an   Franceschi, Silvia ^an   Riboli, Elio ^z   more..

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e KAROLINSKA INSTITUTE   (Sweden)

^f UNIVERSITY OF TROMSØ   (Norway)

^g DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^h NATIONAL CANCER INSTITUTE   (Italy)

ⁱ CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^j UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^k UNIVERSITY OF WASHINGTON   (United States)

^l Fred Hutchinson Cancer Research Center   (United States)

^m AARHUS UNIVERSITY   (Denmark)

ⁿ CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^o UNIVERSITÉ PARIS SACLAY   (France)

^p IGR   (France)

^q UMEÅ UNIVERSITY   (Sweden)

^r GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^s HELLENIC HEALTH FOUNDATION   (Greece)

^t UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^u HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^v BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^w CIVILE M P AREZZO HOSPITAL   (Italy)

^x Human Genetics Foundation   (Italy)

^y UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^z IMPERIAL COLLEGE LONDON   (United Kingdom)

^aa NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^ab UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^ac Dipartimento di Medicina Clinica e Chirurgia Federico Ii University ^*  (Norway)

^ad FOLKHÄLSAN RESEARCH CENTER   (Finland)

^ae PUBLIC HEALTH DIRECTORATE   (Spain)

^af ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^ag Instituto Biosanitario de Granada ibs GRANADA   (Spain)

^ah DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^ai UNIVERSITY OF MURCIA   (Spain)

^aj INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^ak Public Health Division of Gipuzkoa   (Spain)

^al LUND UNIVERSITY HOSPITAL   (Sweden)

^am UNIVERSITY OF OXFORD   (United Kingdom)

^an INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

more..

Author keywords

cervical cancer; cohort study; EPIC; Human Papillomavirus serology; smoking

Indexed keywords

BACTERIUM ANTIBODY; VIRUS ANTIBODY;

ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER RISK; CASE CONTROL STUDY; CHLAMYDIA TRACHOMATIS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; INVASIVE UTERINE CERVIX CANCER; MAJOR CLINICAL STUDY; MARRIAGE; MENOPAUSE; ORAL CONTRACEPTIVE USE; PRECANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SMOKING; SMOKING CESSATION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

CERVICAL CANCER; COHORT STUDY; EPIC; HUMAN PAPILLOMAVIRUS SEROLOGY; SMOKING;

ADULT; AGED; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; SMOKING; UTERINE CERVICAL NEOPLASMS;

EID: 84900037223     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28666     Document Type: Article

References (39)

1. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.
2. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-65.
3. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004; 83: 1-1438.
4. Appleby P, Beral V, Berrington dG, et al. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006; 118: 1481-95.
5. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002; 5: 1113-24.
6. Waterboer T, Sehr P, Michael KM, et al. Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem 2005; 51: 1845-53.
7. Sehr P, Muller M, Hopfl R, et al. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. J Virol Methods 2002; 106: 61-70.
8. Clifford GM, Shin HR, Oh JK, et al. Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea. Cancer Epidemiol Biomarkers Prev 2007; 16: 1874-9.
9. Cust AE, Smith BJ, Chau J, et al. Validity and repeatability of the EPIC physical activity questionnaire: a validation study using accelerometers as an objective measure. Int J Behav Nutr Phys Act 2008; 5: 33.
10. Leffondre K, Abrahamowicz M, Siemiatycki J, et al. Modeling smoking history: a comparison of different approaches. Am J Epidemiol 2002; 156: 813-23.
11. Castle PE, Wacholder S, Lorincz AT, et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst 2002; 94: 1406-14.
12. Ho GY, Kadish AS, Burk RD, et al. HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia. Int J Cancer 1998; 78: 281-5.
13. Plummer M, Herrero R, Franceschi S, et al. Smoking and cervical cancer: pooled analysis of the IARC multi-centric case-control study. Cancer Causes Control 2003; 14: 805-14.
14. Harris TG, Kulasingam SL, Kiviat NB, et al. Cigarette smoking, oncogenic human papillomavirus, Ki-67 antigen, and cervical intraepithelial neoplasia. Am J Epidemiol 2004; 159: 834-42.
15. McIntyre-Seltman K, Castle PE, Guido R, et al. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol Biomarkers Prev 2005; 14: 1165-70.
16. Jensen KE, Schmiedel S, Frederiksen K, et al. Risk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 2012; 21: 1949-55.
17. Daling JR, Madeleine MM, McKnight B, et al. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol Biomarkers Prev 1996; 5: 541-8.
18. Kjellberg L, Hallmans G, Ahren AM, et al. Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer 2000; 82: 1332-8.
19. Shields TS, Brinton LA, Burk RD, et al. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus. Cancer Epidemiol Biomarkers Prev 2004; 13: 1574-82.
20. Olsen AO, Dillner J, Skrondal A, et al. Combined effect of smoking and human papillomavirus type 16 infection in cervical carcinogenesis. Epidemiology 1998; 9: 346-9.
21. Gunnell AS, Tran TN, Torrang A, et al. Synergy between cigarette smoking and human papillomavirus type 16 in cervical cancer in situ development. Cancer Epidemiol Biomarkers Prev 2006; 15: 2141-7.
22. Kapeu AS, Luostarinen T, Jellum E, et al. Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks. Am J Epidemiol 2009; 169: 480-8.
23. McIntyre-Seltman K, Castle PE, Guido R, et al. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol Biomarkers Prev 2005; 14: 1165-70.
24. Jensen KE, Schmiedel S, Frederiksen K, et al. Risk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 2012; 21: 1949-55.
25. Trimble CL, Genkinger JM, Burke AE, et al. Active and passive cigarette smoking and the risk of cervical neoplasia. Obstet Gynecol 2005; 105: 174-81.
26. Castellsague X, Bosch FX, Munoz N,. Environmental co-factors in HPV carcinogenesis. Virus Res 2002; 89: 191-9.
27. Castellsague X, Munoz N,. Chapter 3: Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 2003; 20-8.
28. Munoz N, Castellsague X, de Gonzalez AB, et al. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006; 24 (Suppl 3): S3-1-S310.
29. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer 2007; 120: 885-891.
30. Ylitalo N, Sorensen P, Josefsson A, et al. Smoking and oral contraceptives as risk factors for cervical carcinoma in situ. Int J Cancer 1999; 81: 357-65.
31. Louie KS, Castellsague X, de Sanjose S, et al. Smoking and passive smoking in cervical cancer risk: pooled analysis of couples from the IARC multicentric case-control studies. Cancer Epidemiol Biomarkers Prev 2011; 20: 1379-90.
32. Zeng XT, Xiong PA, Wang F, et al. Passive smoking and cervical cancer risk: a meta-analysis based on 3,230 cases and 2,982 controls. Asian Pac J Cancer Prev 2012; 13: 2687-93.
33. Vaccarella S, Herrero R, Snijders PJ, et al. Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. Int J Epidemiol 2008; 37: 536-46.
34. Collins S, Rollason TP, Young LS, et al. Cigarette smoking is an independent risk factor for cervical intraepithelial neoplasia in young women: a longitudinal study. Eur J Cancer 2010; 46: 405-11.
35. Poppe WA, Ide PS, Drijkoningen MP, et al. Tobacco smoking impairs the local immunosurveillance in the uterine cervix. An immunohistochemical study. Gynecol Obstet Invest 1995; 39: 34-8.
36. Szarewski A, Maddox P, Royston P, et al. The effect of stopping smoking on cervical Langerhans' cells and lymphocytes. BJOG 2001; 108: 295-303.
37. Prokopczyk B, Cox JE, Hoffmann D, et al. Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst 1997; 89: 868-73.
38. Nelson W, Moser RP, Gaffey A, et al. Adherence to cervical cancer screening guidelines for U.S. women aged 25-64: data from the 2005 Health Information National Trends Survey (HINTS). J Womens Health (Larchmt) 2009; 18: 1759-68.
39. Stanley M, Pinto LA, Trimble C,. Human papillomavirus vaccines-immune responses. Vaccine 2012; 30 (Suppl 5): F83-F87.